ArticleOncogene2022
Correction: SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling.
Zhuoxian Rong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleOncogene2022
Zhuoxian Rong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.